Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch | Fierce Pharma
Teva plans to sell Irvine drug plant – Orange County Register
Teva Pharmaceuticals v. Sandoz: Supreme Court Sides with Teva in Patent Case, Holds That Appeals Court Must Review Factual Findings Underlying Claim Construction for “Clear Error” – Policy & Medicine